Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Regenerative medicine shows promise for improving hair and skin but needs more research for standard use.

Combining two treatments for hair loss works better than using just one.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Certain micronutrients may improve hair and nail health, but more research is needed to confirm their benefits.

The conclusion is that modifying scalp lifting surgery by cutting one occipital artery and making other changes reduces complications and improves outcomes for patients with severe hair loss.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Researchers created a new system to classify male baldness, finding six types and a common hairline shape, to improve hair loss treatments.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

No link found between new male baldness genes and female hair loss.

Gene differences may affect baldness treatment response in Korean men.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Hormone treatment caused hair loss, finasteride helped regrowth.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

There's no significant link between blood fat levels and male pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.